Subaru global production rises 0.7% in August 2026 to 61,063 vehicles

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Moderna Inc. advanced 4.8% to $196.48 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 27,538.69 and Dow Jones Industrial Average falling 0.7% to 51,179.87. Moderna Inc. closed 7.4% short of its 52-week high of $212.22, which the company achieved on October 6th. The stock outperformed some of its peers, as Johnson & Johnson rose 1.4% to $258.45, Pfizer Inc. rose 1.8% to $28.00, and Gilead Sciences Inc. rose 1.82% to $146.85. Trading volume totaled 14.6 million, compared to the 50-day average of 20.7 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 07, 2026 16:33 ET (20:33 GMT)

October 7 — Wolfspeed (WOLF.N), a chip company, saw its stock price rise by 27.4% in after-hours trading to $39.89. Wolfspeed announced it has received a conditional loan commitment of up to $1.5 billion over 30 years from the U.S. Department of Defense to expand domestic production of silicon carbide materials and power devices. “We believe the size of this conditional commitment and its 30-year duration reflect the long-term importance of Wolfspeed’s technical and manufacturing capabilities established in the U.S.,” said CEO Robert Feurle. As of the last trading day’s close, the company’s stock has risen about 80% year-to-date. (For the convenience of non-English speakers, Reuters has automated the translation of its report into several languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of these texts and provides them solely for readers’ convenience. Reuters bears no responsibility for any damages or losses caused by the use of automated translations.)